174 related articles for article (PubMed ID: 21595852)
1. Comparison between whole and intact parathyroid hormone assays.
Taniguchi M; Tanaka M; Hamano T; Nakanishi S; Fujii H; Kato H; Koiwa F; Ando R; Kimata N; Akiba T; Kono T; Yokoyama K; Shigematsu T; Kakuta T; Kazama JJ; Tominaga Y; Fukagawa M
Ther Apher Dial; 2011 Jun; 15 Suppl 1():42-9. PubMed ID: 21595852
[TBL] [Abstract][Full Text] [Related]
2. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
Fujimori A; Sakai M; Yoshiya K; Shin J; Kim JI; Inaba Y; Miyamoto T; Inoue S; Fukagawa M
Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy.
Kato Y; Yamaguchi S; Yachiku S; Fujisawa M; Kawakami N
Hinyokika Kiyo; 2004 Nov; 50(11):755-62. PubMed ID: 15628534
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.
Morita A; Tabata T; Koyama H; Emoto M; Inoue T; Miki T; Nishizawa Y; Morii H
Clin Nephrol; 1992 Sep; 38(3):154-7. PubMed ID: 1395169
[TBL] [Abstract][Full Text] [Related]
6. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
7. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
Melamed ML; Eustace JA; Plantinga LC; Jaar BG; Fink NE; Parekh RS; Coresh J; Yang Z; Cantor T; Powe NR
Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
[TBL] [Abstract][Full Text] [Related]
8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
9. Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia.
Kazama JJ; Omori T; Ei I; Ei K; Oda M; Maruyama H; Narita I; Gejyo F; Shigematsu T; Fukagawa M
Clin Exp Nephrol; 2003 Jun; 7(2):144-9. PubMed ID: 14586733
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three different immunoassay methods for the evaluation of intact parathyroid hormone levels in hemodialysis patients.
Ates F; Koken T; Demir S; Kahraman A; Dogan N
Scand J Clin Lab Invest; 2011 May; 71(3):227-31. PubMed ID: 21294669
[TBL] [Abstract][Full Text] [Related]
11. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
[TBL] [Abstract][Full Text] [Related]
12. [Significance of a new PTH assay (the comparison between whole-PTH and intact-PTH assay)].
Ito N; Fukumoto S
Clin Calcium; 2004 Sep; 14(9):55-6. PubMed ID: 15577110
[TBL] [Abstract][Full Text] [Related]
13. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
14. [Intact whole bioactive parathormone: problems arising from comparing different methods].
Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D
G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of IDS-iSYS intact parathyroid hormone (iPTH) and comparison to Siemens Advia Centaur iPTH assay in chronic renal failure patients and in controls.
Koivula MK; Laitinen P; Risteli J
Clin Lab; 2012; 58(5-6):403-10. PubMed ID: 22783568
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay.
Tsuchida T; Ishimura E; Hirowatari K; Matsumoto N; Imanishi Y; Jono S; Miki T; Inaba M; Nishizawa Y
Nephron Clin Pract; 2006; 102(3-4):c108-14. PubMed ID: 16286785
[TBL] [Abstract][Full Text] [Related]
17. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays.
Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M
Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732
[TBL] [Abstract][Full Text] [Related]
18. The role of quick bio-intact PTH(1-84) assay during parathyroidectomy for secondary hyperparathyroidism.
Ikeda Y; Kurihara H; Morita N; Miyabe R; Takami H
J Surg Res; 2007 Aug; 141(2):306-10. PubMed ID: 17418873
[TBL] [Abstract][Full Text] [Related]
19. High serum levels of a non-(1-84) parathyroid hormone (PTH) fragment in pediatric haemodialysis patients.
Salomon R; Charbit M; Gagnadoux MF; Niaudet P; Gao P; Cantor T; Souberbielle JC
Pediatr Nephrol; 2001 Dec; 16(12):1011-4. PubMed ID: 11793090
[TBL] [Abstract][Full Text] [Related]
20. Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism.
Yamashita H; Cantor T; Uchino S; Watanabe S; Ogawa T; Moriyama T; Takamatsu Y; Fukagawa M; Noguchi S
World J Surg; 2005 Feb; 29(2):169-73. PubMed ID: 15650804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
